Analysis of neutrophil extracellular traps in hypercoagulability and portal vein thrombosis in liver cirrhosis patients

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100047466

Enrollment

Unknown

Registered

2021-06-19

Start date

2021-07-01

Completion date

Unknown

Last updated

2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

portal vein thrombosis in patients with cirrhosis

Interventions

PVT group:No

non-PVT group:No

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients with cirrhosis diagnosed in accordance with the 2019 Guidelines for the Diagnosis and Treatment of Cirrhosis; 2. In accordance with the diagnostic criteria of portal vein thrombosis in the 2015 European Society of Hepatology Clinical Practice Guidelines: Hepatic Vascular Diseases.

Exclusion criteria

Exclusion criteria: 1. Patients with primary or secondary liver malignancy; 2. patients with hematologic diseases; 3. patients with Bud-Chiah syndrome; 4. Patients with incomplete data.

Design outcomes

Primary

Measure	Time frame
neutrophil extracellular traps;	—

Secondary

Measure	Time frame
thrombin antithrombin complex;	—

Countries

China

Contacts

Public ContactJing Xue

The Affiliated Hospital of Qingdao University

jingxue@qdu.edu.cn+86 18661807575

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026